Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Luteal Phase After GnRHa Trigger - a Proof of Concept Study
Brief Summary: The purpose of this study is to investigate levels of progesterone in the luteal phase after various stimulations in the follicular phase and treatment with GnRH antagonist protocol followed by GnRHagonist as induction of ovulation.


Options:
A: Arm Label: Menotropin/Progesterone vaginal insert; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone vaginal insert, Drug: leuprolide acetate | Arm Label: Menotropin/Progesterone in oil; Type: EXPERIMENTAL; Interventions: Drug: Menotropin, Drug: Progesterone in oil, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone vaginal insert; Type: ACTIVE_COMPARATOR; Interventions: Drug: Progesterone vaginal insert, Drug: Follitropin beta, Drug: leuprolide acetate | Arm Label: Follitropin beta/Progesterone in oil; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin beta, Drug: Progesterone in oil, Drug: leuprolide acetate | Intervention Type: DRUG; Name: Menotropin; Assigned to Arm(s): Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone vaginal insert; Assigned to Arm(s): Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone vaginal insert | Intervention Type: DRUG; Name: Follitropin beta; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert | Intervention Type: DRUG; Name: Progesterone in oil; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Menotropin/Progesterone in oil | Intervention Type: DRUG; Name: leuprolide acetate; Assigned to Arm(s): Follitropin beta/Progesterone in oil, Follitropin beta/Progesterone vaginal insert, Menotropin/Progesterone in oil, Menotropin/Progesterone vaginal insert
B: Arm Label: hCG in the late follicular phase + luteal phase; Type: EXPERIMENTAL; Interventions: Drug: hCG(r-hCG, Ovitrelle, Merck-Serono, Hellerup, Denmark) in the late follicular phase + luteal phase | Arm Label: hCG in the follicular phase + luteal phase; Type: EXPERIMENTAL; Interventions: Drug: hCG(r-hCG, Ovitrelle,Merck-Serono, Hellerup, Denmark) in the follicular phase + luteal phase | Arm Label: LH in the luteal phase; Type: EXPERIMENTAL; Interventions: Drug: LH(r-LH,Luveris, Merck-Serono, Hellerup, Denmark) in the luteal phase | Arm Label: vaginal progesterone and estradiol in the luteal phase; Type: ACTIVE_COMPARATOR; Interventions: Drug: vaginal progesterone(Crinone; Merck-Serono, Hellerup, Denmark) and estradiol(Estrofem; Novo Nordisk, Copenhagen, Denmark) in the luteal phase | Intervention Type: DRUG; Name: hCG(r-hCG, Ovitrelle, Merck-Serono, Hellerup, Denmark) in the late follicular phase + luteal phase; Assigned to Arm(s): hCG in the late follicular phase + luteal phase | Intervention Type: DRUG; Name: hCG(r-hCG, Ovitrelle,Merck-Serono, Hellerup, Denmark) in the follicular phase + luteal phase; Assigned to Arm(s): hCG in the follicular phase + luteal phase | Intervention Type: DRUG; Name: LH(r-LH,Luveris, Merck-Serono, Hellerup, Denmark) in the luteal phase; Assigned to Arm(s): LH in the luteal phase | Intervention Type: DRUG; Name: vaginal progesterone(Crinone; Merck-Serono, Hellerup, Denmark) and estradiol(Estrofem; Novo Nordisk, Copenhagen, Denmark) in the luteal phase; Assigned to Arm(s): vaginal progesterone and estradiol in the luteal phase
C: Arm Label: micronized progesterone; Type: EXPERIMENTAL; Interventions: Drug: micronized progesterone | Arm Label: no utrogestan; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: micronized progesterone; Assigned to Arm(s): micronized progesterone
D: Arm Label: Young postmenopausal women; Type: EXPERIMENTAL; Interventions: Drug: GnRH, Drug: NAL-GLU GnRH antagonist, Drug: Estrogen patch | Arm Label: Older postmenopausal women; Type: EXPERIMENTAL; Interventions: Drug: GnRH, Drug: NAL-GLU GnRH antagonist, Drug: Estrogen patch | Intervention Type: DRUG; Name: GnRH; Assigned to Arm(s): Older postmenopausal women, Young postmenopausal women | Intervention Type: DRUG; Name: NAL-GLU GnRH antagonist; Assigned to Arm(s): Older postmenopausal women, Young postmenopausal women | Intervention Type: DRUG; Name: Estrogen patch; Assigned to Arm(s): Older postmenopausal women, Young postmenopausal women

Answer: B